Health Headlines for Wednesday, November 28
Telemedicine surging in US but still uncommon
Reuters
Although telemedicine visits have increased sharply in the U.S. in recent years, the vast majority of American adults still receive care from doctors in person rather than via remote technology, a new study suggests.
Chronically Ill, Traumatically Billed: The $123,000 Medicine For MS
Kaiser Health News
Shereese Hickson’s multiple sclerosis was flaring again. Spasms in her legs and other symptoms were getting worse.
Election aftermath: What’s next for health care?
Albany Business Review
As the dust begins to settle following one of the most hotly contested midterms in American history, many are now asking – what’s next for health care?
Drug prices a bipartisan bright spot following midterms, experts say
Fierce Healthcare
Although the results of the midterms signal a likely end to much of the uncertainty in healthcare policy caused by partisan wrangling the past couple of years, experts say it’s likely Democrats and Republicans will find at least incremental ways to work together ahead of the 2020 presidential race
Could Sanders’ plan to lower drug prices backfire?
Modern Healthcare
Sen. Bernie Sanders’ bill threatening to cut pharmaceutical companies’ patent protections if their drug prices are too high has been hailed by some patient advocates as one of the first solid solutions to one of the healthcare industry’s most talked about issues.
Generic EpiPen not any cheaper than existing version
The Hill
A generic competitor to the EpiPen won’t cost any less than the version already on the market, despite the Trump administration touting it as a cheaper alternative.